Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

Bing Sen Zhou, Pamela Tsai, Rhonda Ker, Jeffrey Tsai, Roger Ho, Johnathan Yu, Jennifer Shih, Yun Yen

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The ribonucleotide reductase (RR) gene has been associated with malignant transformation and metastatic potential. In this report, the significance of the expression of RR mRNA and enzymatic activity to the invasive potential was examined by Boyden chamber invasion assay. Our results suggest that overexpression of RR M2 mRNA and RR enzymatic activity correlates to an increase in cell invasive potential. The drug-induced HURs clone expressed a higher level RR M2 mRNA and enzyme activity which contributes significantly to the 3-fold increase in invasive potential of the cells observed relative to the KB wild-type control. On the contrary, the HUr revertant clone decreased the RR M2 mRNA level and enzymatic activity, concomitantly decreasing their invasive potential. This phenomenon is most likely due to the return of RR to levels comparable to that of the KB wild- type cells. To confirm that this observation was not of a drug-resistance phenotype associated with multiple gene alterations, the panel of RR transfectants (M1-D transfected M1 subunit cDNA, M2-D transfected M2 subunit cDNA, X-D transfected M1/M2 cDNA) characterized in a previous study were also tested in the invasion assay. The M2-D clone expressed 6-fold higher RR M2 mRNA and RR activity and also demonstrated 6-fold higher invasive potential in vitro than either the parental or vector only transfected cell line (KB- V). The X-D clone demonstrated 3-fold higher M2 mRNA expression and revealed 4-fold higher invasive potential than control cells. The M1-D clone, in contrast, expressed a baseline level of RR M2 mRNA and higher M1 mRNA. In contrast to the X-D and M2-D cells, the invasive potential of M1-D reached an even lower level in the invasive assay than the control. These results, therefore, suggest that RR M2 overexpression plays an important role in a tumor's invasiveness.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalClinical and Experimental Metastasis
Volume16
Issue number1
DOIs
Publication statusPublished - Mar 31 1998
Externally publishedYes

Fingerprint

Ribonucleotide Reductases
Messenger RNA
Clone Cells
Neoplasms
Complementary DNA
KB Cells
Somatostatin-Secreting Cells
ribonucleotide reductase M2
Drug Resistance
Genes
Phenotype
Cell Line
Enzymes
Pharmaceutical Preparations

Keywords

  • Hydroxyurea
  • Metastatic
  • Ribonucleotide reductase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. / Zhou, Bing Sen; Tsai, Pamela; Ker, Rhonda; Tsai, Jeffrey; Ho, Roger; Yu, Johnathan; Shih, Jennifer; Yen, Yun.

In: Clinical and Experimental Metastasis, Vol. 16, No. 1, 31.03.1998, p. 43-49.

Research output: Contribution to journalArticle

Zhou, Bing Sen ; Tsai, Pamela ; Ker, Rhonda ; Tsai, Jeffrey ; Ho, Roger ; Yu, Johnathan ; Shih, Jennifer ; Yen, Yun. / Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. In: Clinical and Experimental Metastasis. 1998 ; Vol. 16, No. 1. pp. 43-49.
@article{534ca45fc41641e5b526df15b367da01,
title = "Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential",
abstract = "The ribonucleotide reductase (RR) gene has been associated with malignant transformation and metastatic potential. In this report, the significance of the expression of RR mRNA and enzymatic activity to the invasive potential was examined by Boyden chamber invasion assay. Our results suggest that overexpression of RR M2 mRNA and RR enzymatic activity correlates to an increase in cell invasive potential. The drug-induced HURs clone expressed a higher level RR M2 mRNA and enzyme activity which contributes significantly to the 3-fold increase in invasive potential of the cells observed relative to the KB wild-type control. On the contrary, the HUr revertant clone decreased the RR M2 mRNA level and enzymatic activity, concomitantly decreasing their invasive potential. This phenomenon is most likely due to the return of RR to levels comparable to that of the KB wild- type cells. To confirm that this observation was not of a drug-resistance phenotype associated with multiple gene alterations, the panel of RR transfectants (M1-D transfected M1 subunit cDNA, M2-D transfected M2 subunit cDNA, X-D transfected M1/M2 cDNA) characterized in a previous study were also tested in the invasion assay. The M2-D clone expressed 6-fold higher RR M2 mRNA and RR activity and also demonstrated 6-fold higher invasive potential in vitro than either the parental or vector only transfected cell line (KB- V). The X-D clone demonstrated 3-fold higher M2 mRNA expression and revealed 4-fold higher invasive potential than control cells. The M1-D clone, in contrast, expressed a baseline level of RR M2 mRNA and higher M1 mRNA. In contrast to the X-D and M2-D cells, the invasive potential of M1-D reached an even lower level in the invasive assay than the control. These results, therefore, suggest that RR M2 overexpression plays an important role in a tumor's invasiveness.",
keywords = "Hydroxyurea, Metastatic, Ribonucleotide reductase",
author = "Zhou, {Bing Sen} and Pamela Tsai and Rhonda Ker and Jeffrey Tsai and Roger Ho and Johnathan Yu and Jennifer Shih and Yun Yen",
year = "1998",
month = "3",
day = "31",
doi = "10.1023/A:1006559901771",
language = "English",
volume = "16",
pages = "43--49",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

AU - Zhou, Bing Sen

AU - Tsai, Pamela

AU - Ker, Rhonda

AU - Tsai, Jeffrey

AU - Ho, Roger

AU - Yu, Johnathan

AU - Shih, Jennifer

AU - Yen, Yun

PY - 1998/3/31

Y1 - 1998/3/31

N2 - The ribonucleotide reductase (RR) gene has been associated with malignant transformation and metastatic potential. In this report, the significance of the expression of RR mRNA and enzymatic activity to the invasive potential was examined by Boyden chamber invasion assay. Our results suggest that overexpression of RR M2 mRNA and RR enzymatic activity correlates to an increase in cell invasive potential. The drug-induced HURs clone expressed a higher level RR M2 mRNA and enzyme activity which contributes significantly to the 3-fold increase in invasive potential of the cells observed relative to the KB wild-type control. On the contrary, the HUr revertant clone decreased the RR M2 mRNA level and enzymatic activity, concomitantly decreasing their invasive potential. This phenomenon is most likely due to the return of RR to levels comparable to that of the KB wild- type cells. To confirm that this observation was not of a drug-resistance phenotype associated with multiple gene alterations, the panel of RR transfectants (M1-D transfected M1 subunit cDNA, M2-D transfected M2 subunit cDNA, X-D transfected M1/M2 cDNA) characterized in a previous study were also tested in the invasion assay. The M2-D clone expressed 6-fold higher RR M2 mRNA and RR activity and also demonstrated 6-fold higher invasive potential in vitro than either the parental or vector only transfected cell line (KB- V). The X-D clone demonstrated 3-fold higher M2 mRNA expression and revealed 4-fold higher invasive potential than control cells. The M1-D clone, in contrast, expressed a baseline level of RR M2 mRNA and higher M1 mRNA. In contrast to the X-D and M2-D cells, the invasive potential of M1-D reached an even lower level in the invasive assay than the control. These results, therefore, suggest that RR M2 overexpression plays an important role in a tumor's invasiveness.

AB - The ribonucleotide reductase (RR) gene has been associated with malignant transformation and metastatic potential. In this report, the significance of the expression of RR mRNA and enzymatic activity to the invasive potential was examined by Boyden chamber invasion assay. Our results suggest that overexpression of RR M2 mRNA and RR enzymatic activity correlates to an increase in cell invasive potential. The drug-induced HURs clone expressed a higher level RR M2 mRNA and enzyme activity which contributes significantly to the 3-fold increase in invasive potential of the cells observed relative to the KB wild-type control. On the contrary, the HUr revertant clone decreased the RR M2 mRNA level and enzymatic activity, concomitantly decreasing their invasive potential. This phenomenon is most likely due to the return of RR to levels comparable to that of the KB wild- type cells. To confirm that this observation was not of a drug-resistance phenotype associated with multiple gene alterations, the panel of RR transfectants (M1-D transfected M1 subunit cDNA, M2-D transfected M2 subunit cDNA, X-D transfected M1/M2 cDNA) characterized in a previous study were also tested in the invasion assay. The M2-D clone expressed 6-fold higher RR M2 mRNA and RR activity and also demonstrated 6-fold higher invasive potential in vitro than either the parental or vector only transfected cell line (KB- V). The X-D clone demonstrated 3-fold higher M2 mRNA expression and revealed 4-fold higher invasive potential than control cells. The M1-D clone, in contrast, expressed a baseline level of RR M2 mRNA and higher M1 mRNA. In contrast to the X-D and M2-D cells, the invasive potential of M1-D reached an even lower level in the invasive assay than the control. These results, therefore, suggest that RR M2 overexpression plays an important role in a tumor's invasiveness.

KW - Hydroxyurea

KW - Metastatic

KW - Ribonucleotide reductase

UR - http://www.scopus.com/inward/record.url?scp=0031938457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031938457&partnerID=8YFLogxK

U2 - 10.1023/A:1006559901771

DO - 10.1023/A:1006559901771

M3 - Article

C2 - 9502076

AN - SCOPUS:0031938457

VL - 16

SP - 43

EP - 49

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 1

ER -